Dr. Jose Madrazo is a general cardiologist in the Johns Hopkins Division of Medicine, and an assistant professor of medicine at the Johns Hopkins School of Medicine. He received his medical degree from the University of Puerto Rico School of Medicine and completed his residency at the Baylor College of Medicine in Houston, TX. Dr. Madrazo pursued a cardiovascular fellowship with a focus on echocardiography at the Washington University School of Medicine before joining the Hopkins faculty. Dr. Madrazo is rated as a Distinguished provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, and Heart Attack.

Edward K. Kasper, M.D. is a graduate of the Johns Hopkins University with a B.A. in Natural Sciences. He earned his M.D. at the University of Connecticut School of Medicine in 1984. His internship and residency in Internal Medicine, as well as his fellowship in Cardiovascular Medicine, were completed at the Johns Hopkins Hospital, where he then joined the faculty in 1993. He is a fellow of the American Heart Association as well as a fellow of the American College of Cardiology, having served on its board of governors from 2002 to 2006. Dr. Kasper has authored more than 100 articles and three books including, Living Well with Heart Failure. He is currently the Director of Outpatient Cardiology. Dr. Kasper's current research interests focus on the biological origins of heart failure. Specifically, his research has focused on causes and prognosis of patients with cardiomyopathy, a serious condition in which the heart has difficulty pumping blood throughout the body. Dr. Kasper works closely with his team at the Johns Hopkins Heart and Vascular Institute to understand the best ways to predict and prevent catastrophic cardiac events. With your support, Dr. Kasper will be able to continue his significant work in cardiovascular medicine in hopes of impacting the future of patients with cardiomyopathy and heart failure. Dr. Kasper is rated as a Distinguished provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Bradley Maron is a Cardiologist in Baltimore,, Maryland. Dr. Maron is rated as a Distinguished provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Dr. Richard (Rick) Carrick is a general cardiologist in the Johns Hopkins Division of Medicine and is an assistant professor of medicine at the Johns Hopkins School of Medicine. He also serves as associate director of the Johns Hopkins Hypertrophic Cardiomyopathy Center of Excellence. Originally from Massachusetts, he completed his medical training as well as a Ph.D. in Bioengineering at the University of Vermont and did his internal medicine residency training at Tufts Medical Center in Boston, MA. He completed his Cardiovascular Disease Fellowship and a T32 Research Fellowship at Johns Hopkins. His research focuses on the use of advanced computational techniques like machine-learning and artificial intelligence to improve risk stratification in patients with inherited heart disease. Clinically, he specializes in echocardiography and the care of patients with hypertrophic cardiomyopathy (HCM) and other genetic cardiomyopathies. Dr. Carrick is rated as a Distinguished provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Ventricular Tachycardia, Arrhythmias, and Cardiac Ablation.

Daniel Judge is a Cardiologist in Baltimore, Maryland. Dr. Judge is rated as a Distinguished provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation.

Dr. Hugh Calkins is the Catherine Ellen Poindexter Professor of Cardiology and Director of the Electrophysiology Laboratory and Arrhythmia Service at the Johns Hopkins Hospital. He is an internationally recognized expert on catheter ablation, atrial fibrillation, syncope, arrhythmogenic right ventricular dysplasia (ARVD) and arrhythmia management. Dr. Calkins attended Williams College and Harvard Medical School before training in medicine at Massachusetts General Hospital. He received his cardiology training at Johns Hopkins. His first faculty position was at the University of Michigan, where he directed the Pacemaker Service, and he returned to Johns Hopkins as director of the Arrhythmia Service in 1992. Dr. Calkins is an Associate Editor of the Journal of Cardiovascular Electrophysiology and is on the editorial board of many other cardiology journals. He is a former member of the American Board of Internal Medicine Electrophysiology Boards Test Writing Committee. Dr. Calkins is a fellow of the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. He led a 44-member international task force whose 2012 Expert Consensus Statement gave recommendations for treatment and research of atrial fibrillation. Dr Calkins is a past president of the Heart Rhythm Society and was elected to be a member of the Miler Coulsen Academy of Clinical Excellence in 2014. Dr. Calkins has published more than 500 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. Dr. Calkins is rated as an Advanced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Heart Transplant.

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Advanced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Joseph Marine, MD, MBA, FACC, FHRS, is a clinical cardiac electrophysiologist who practices primarily at the Johns Hopkins Hospital in Baltimore, Maryland. He is a Professor of Medicine at the Johns Hopkins University School of Medicine and holds appointments as Vice-Director of Operations for the Division of Cardiology and Section Chief of Cardiology for Johns Hopkins Community Physicians. He trained at UC San Francisco Medical School, Brigham and Women’s Hospital/Harvard Medical School, Boston University Medical Center, and Beth Israel Deaconess Medical Center. Dr. Marine has lectured widely on a variety of arrhythmia topics and has served as a co-director of the American College of Cardiology (ACC) Cardiovascular Overview and Board Review Course for 10 years. He currently serves on the ACC Board of Governors and is co-editor of the ACC/HRS EP Self-Assessment Program. He also serves on other committees for the ACC, the Heart Rhythm Society, and MedChi. He is co-author of more than 130 original research and review articles and has served on writing committees for several national cardiology practice and training guidelines. As a clinical cardiac electrophysiologist, Dr. Marine specializes in the diagnosis and treatment of arrhythmias, which are heart rhythm disorders that cause the heart to beat too rapidly, too slowly, or irregularly. His research focuses on further improving the safety and effectiveness of catheter ablation and other treatments for atrial fibrillation and other atrial and ventricular arrhythmias. Dr. Marine is rated as an Advanced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Atrial Fibrillation, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Arrhythmias, Cardiac Ablation, and Heart Transplant.

Jonathan Chrispin, M.D., is an Associate Professor of Medicine in the Johns Hopkins Medicine Division of Cardiology, Electrophysiology and Arrhythmia, as well as an Associate Professor of Biomedical Engineering at Johns Hopkins University. Dr. Chrispin focuses on all aspects of clinical electrophysiology, including pacemaker/defibrillator implantation and complex catheter ablation for atrial and ventricular arrhythmias. Dr. Chrispin received his Bachelor of Arts degree from Harvard University. He received his Doctor of Medicine degree from Vanderbilt University. He completed intern and residency training in internal medicine at The Johns Hopkins Hospital, where he also completed a fellowship in cardiovascular disease and served as chief clinical cardiac electrophysiology fellow. He is a member of the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society. Dr. Chrispin directs the Ventricular Arrhythmia Ablation and Research program, focusing on using advanced cardiac imaging to better understand the structural substrate associated with the development of ventricular arrhythmias and using artificial intelligence to improve the risk stratification of sudden cardiac death. Further, he is involved in developing clinical trials to improve the safety and efficacy of catheter ablation for the treatment of ventricular tachycardia. His work has led to Dr. Chrispin publishing in a number of international journals, including Circulation, the Journal of the American College of Cardiology, Heart Rhythm Journal, Nature Cardiovascular Research, Journal of the American Heart Association, and EP Europace. Dr. Chrispin is rated as an Advanced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Ventricular Tachycardia, Arrhythmias, Sarcoidosis, Cardiac Ablation, and Pacemaker Implantation.

Jeremy Pollock is a Cardiologist in Towson, Maryland. Dr. Pollock is rated as an Advanced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Atrial Fibrillation, Heart Attack, and Apoplexy.

Vivek Varma is a Cardiologist in Elkton,, Maryland. Dr. Varma is rated as an Advanced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Pacemaker Implantation, and Angioplasty.

Shelby Kutty is a Pediatric Cardiologist in Baltimore,, Maryland. Dr. Kutty is rated as an Advanced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot, Congenital Heart Disease (CHD), Heart Transplant, and Percutaneous Coronary Intervention (PCI).

Thomas Odar is a Cardiologist in Rockville,, Maryland. Dr. Odar is rated as an Advanced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Atrial Fibrillation, Mitral Valve Regurgitation, Aortic Regurgitation, and Mitral Valve Prolapse.

Dr. Tigist Hailu is a general cardiologist in the Johns Hopikins Heart and Vascular Institute of the Division of Medicine. She practices at Johns Hopkins Cardiology at the Greater Baltimore Medical Center (GBMC) and at Johns Hopkins Medicine, White Marsh. Dr. Hailu is also an instructor of medicine at the Johns Hopkins University School of Medicine. Dr. Hailu received her medical degree from the Yale University School of Medicine. She completed her medical residency at the Hospital of the University of Pennsylvania and pursued a fellowship in cardiology at New York Presbyterian Hospital, Cornell Campus. Dr. Hailu is rated as an Experienced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). Her top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Subvalvular Aortic Stenosis, and Angina.

Dr. Barouch is Associate Professor of Medicine in the Division of Cardiology, Department of Medicine, and a member of the Advanced Heart Failure and Cardiac Transplantation group at Johns Hopkins Hospital. Dr. Barouch received her undergraduate degree from Harvard University in 1992 and her medical degree from Johns Hopkins in 1996. She continued at Johns Hopkins for residency training in Internal Medicine, completed in 1999, and fellowship in Cardiovascular Disease and Advanced Heart Failure/Transplant, completed in 2003. She has expertise in the outpatient management of advanced heart failure and many types of cardiomyopathies. Dr. Barouch also has a longstanding interest in women’s cardiovascular health – particularly in how some cardiac conditions affect women differently or present with distinctive symptoms. She is the Medical Director of the Columbia Heart Failure Clinic, in partnership with Johns Hopkins Howard County Medical Center, and the Howard County Director of the Women’s Cardiovascular Health Center. She is also the Director of the Sports Cardiology Program, which offers expert cardiac care specifically geared towards athletes of all abilities. Dr. Barouch believes that educating people about heart disease, medications and lifestyle changes, including healthy eating habits and regular exercise, is critically important in helping her patients understand how to achieve and maintain wellness and feel in control of their cardiovascular health. She is an avid runner and triathlete herself, competing in several triathlons and other races per year, as well as the occasional marathon. Dr. Barouch is rated as an Experienced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). Her top areas of expertise are Cardiomyopathy, Cardiac Amyloidosis, Arrhythmogenic Right Ventricular Cardiomyopathy, and Primary Localized Cutaneous Amyloidosis.

Dr. Katherine Wu is a general cardiologist for the Heart and Vascular Institute at Johns Hopkins Medicine with an interest in caring for patients with cardiomyopathies, coronary artery disease, and valvular heart disease as well as those interested in cardiovascular prevention. She has additional expertise in non-invasive cardiology imaging techniques. Dr. Wu received her medical degree from the University of Pennsylvania Health System School of Medicine, and completed her residency and a cardiology fellowship at the Johns Hopkins University School of Medicine. She joined the School of Medicine faculty in 2000. Dr. Wu's research interests include improving individualized risk prediction for sudden cardiac death and heart failure by developing and validating methods that incorporate novel cardiac imaging indices. Her lab is funded by the NIH/NHLBI. Dr. Wu has more than 70 peer-reviewed publications and serves on the editorial board of the Journal of Cardiovascular Magnetic Resonance and Circulation Cardiovascular Imaging and is a standing member of the NIH Clinical and Integrative Cardiovascular Sciences Study Section. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). Her top areas of expertise are Cardiomyopathy, Atrial Fibrillation, Heart Attack, and Pulmonary Hypertension.

Dr. Stacy Fisher is a cardiologist in Baltimore, Maryland specializing in the care of adult congenital heart disease, pregnancy-related heart disease and congenital heart pulmonary hypertension. She is Associate Director of the Adult Congenital Heart Disease (ACHD) Center at the Johns Hopkins Heart and Vascular Institute and Director of the ACHD Training Program. She is also an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her research focus is congenital heart disease in adults including pulmonary hypertension, inherited heart disease and 3D printing translational medicine. She is interested in imaging and using 3D modeling to advance cardiac care and education. Her education includes a Bachelor of Science degree in Microbiology from Miami University in Oxford, Ohio, and a Doctor of Medicine Degree from the University of Maryland School of Medicine in Baltimore, Maryland. She completed an internship and residency in Internal Medicine at Duke University in Durham, North Carolina. Her fellowship in cardiology was at the University of Rochester, Strong Memorial Hospital in Rochester, New York, including serving as the Chief Cardiology Fellow. She was then an Adult Congenital Heart Fellow at the University of Rochester, Strong Memorial Hospital. After completing her fellowship in 2001, she joined a Baltimore cardiology practice and was named Director of Women’s Cardiovascular Services and the Co-Director of the Cardiac Critical Care Unit at Sinai Hospital in Baltimore, positions which she held until 2011. She then joined University of Maryland School of Medicine as Director of Women’s and Complex Heart diseases where she started and directed the Adult Congenital Heart Program and practiced through 2022 when she joined Johns Hopkins. She was recently the President of the American Heart Association’s Greater Maryland Region. Videos Dr. Stacy Fisher. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). Her top areas of expertise are Familial Ventricular Tachycardia, Arrhythmias, Ventricular Tachycardia, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Andreas S. Barth is an Associate Professor in the Division of Cardiology at the Johns Hopkins School of Medicine and Director of the Center for Inherited Heart Diseases. His clinical work focuses on clinical cardiac electrophysiology with a specific focus on inherited arrhythmia syndromes and channelopathies, including long QT syndrome, Brugada syndrome, CPVT and arrhythmogenic cardiomyopathies. Additionally, Dr. Barth participates in a multidisciplinary clinic at Kennedy Krieger Institute providing Cardiology care to patients with muscular dystrophies and mitochondrial disease. Dr. Barth performs pacemaker and defibrillator implantation and complex catheter ablations for atrial and ventricular arrhythmias. His basic research lab explores the relationship between metabolic and arrhythmogenic ion channel remodeling in heart failure and myotonic dystrophy. Dr. Barth earned a combined doctor of medicine and doctor of philosophy from the Ludwig-Maximilians-University in Munich, Germany. He joined the Johns Hopkins faculty in 2016. He has been recognized with the First Prize for the Stanley L. Blumenthal Cardiology Research Award in Clinical Science in the Division of Cardiology at Johns Hopkins Hospital, and as a Young Investigator Award Finalist of the American Heart Association and Heart Rhythm Society. Dr. Barth is rated as an Experienced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Cardiomyopathy, Arrhythmias, Heart Attack, Cardiac Ablation, and Pacemaker Implantation.

Alan Schneider, M.D., F.A.C.C., received his medical degree from the University of Maryland School of Medicine. He completed his residency in internal medicine and was Chief Resident in Internal Medicine at the University of Maryland Hospital, Baltimore. He then completed fellowships in Cardiology and Cardiac Electrophysiology at the University of Maryland Hospital. His special interest is the surgical and medical management of cardiac arrhythmias. Dr. Schneider has been recognized as one of the area’s “Top Doctors” every year by Washingtonian magazine. Dr. Schneider is rated as an Experienced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). His top areas of expertise are Arrhythmias, Atrial Fibrillation, Familial Progressive Cardiac Conduction Defect, Pacemaker Implantation, and Cardiac Ablation.

Dr. Allison Hays is a general cardiologist and Medical Director of Echocardiography Programs at the Johns Hopkins Hospital. She is also an assistant professor at the Johns Hopkins University School of Medicine. Dr. Hays graduated from Stanford University with degrees in biology and English. She received her medical training at the Columbia University College of Physicians and Surgeons and did her residency at the New York Presbyterian Hospital at Columbia. Dr. Hays pursued cardiology fellowships at New York University Medical Center and at the Johns Hopkins University School of Medicine. Dr. Hays studies ways to use noninvasive imaging to detect cardiovascular disease. She has advanced multimodality imaging training from Johns Hopkins and attends in the Adult Echocardiography Lab at Johns Hopkins Hospital. In terms of research, she uses Cardiac MRI as a tool to study coronary and systemic endothelial function. Dr. Hays is rated as an Experienced provider by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). Her top areas of expertise are Familial Ventricular Tachycardia, Cardiomyopathy, COVID-19, Heart Attack, and Tissue Biopsy.